Barely Significant
← all excerpts

Synthetic Lethality-Based Targets and Their Exploration in Tumour Combination Strategies.

J Cell Mol Med · 2025 · PMC12381573 · PMID 40859871

1
hedged sentence
closest p
boldest claim

The sentences

The latest results [ 65 ] showed that the PFS hazard ratios of the niraparib group in the overall cohort, homologous recombination deficiency (HRD) and homologous recombination proficient (HRP) subgroups were 0.66, 0.51, and 0.67, respectively, indicating that niraparib can significantly prolong PFS of patients, but in terms of OS, the hazard ratios of each population were close to 1, which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.